AKEBIA THERAPEUTICS, INC. Available-for-sale Securities
AKEBIA THERAPEUTICS, INC. (AKBA) had Available-for-sale Securities of $76.14 million as of 2014-12-31, per its 10-K filed 2015-03-04.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecurities · last filed 2015-03-04
- 2014-12-31: Available-for-sale Securities $76.14M.
- 2014-09-30: Available-for-sale Securities $68.67M.
- 2014-06-30: Available-for-sale Securities $124.25M.
- 2013-12-31: Available-for-sale Securities $11.34M; Available-for-sale Securities as first filed $32.56M.
| Period end | Available-for-sale Securities | Available-for-sale Securities as first filed |
|---|---|---|
| 2014-12-31 | $76.14M 10-K · filed 2015-03-04 | |
| 2014-09-30 | $68.67M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $124.25M 10-Q · filed 2014-08-11 | |
| 2013-12-31 | $11.34M 10-K · filed 2015-03-04 | $32.56M 10-Q · filed 2014-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |